Safety and Tolerability of Oral Namisol, a Tablet Containing Delta-9-Tetrahydrocannabinol, in Elderly Subjects: A Randomized Controlled Trial

Trial Profile

Safety and Tolerability of Oral Namisol, a Tablet Containing Delta-9-Tetrahydrocannabinol, in Elderly Subjects: A Randomized Controlled Trial

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Jun 2014

At a glance

  • Drugs Dronabinol (Primary)
  • Indications Alzheimer's disease; Multiple sclerosis; Pain
  • Focus Adverse reactions
  • Most Recent Events

    • 24 Jan 2014 Status changed from recruiting to completed, according to ClinicalTrials. gov record.
    • 10 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top